Esterase-induced release of a theranostic prodrug in lysosome for improved therapeutic efficacy and lower systemic toxicity

5-Fluorouracil (5-FU) is the third most used chemotherapeutic agent. Despite being a frontline drug, it inhibits thymidylate synthase in malignant and non-malignant cells, which adds to its severe systemic toxicity....